Publications by authors named "K Tegmark-Wisell"
In 2020, the world had to adapt to a pandemic caused by a then novel coronavirus. In addition to its direct impact on morbidity and mortality, the COVID-19 pandemic brought unprecedented control measures and challenges to both individuals and society. Sweden has been seen by many as an outlier in the management of the pandemic.
View Article and Find Full Text PDFBackground: In order to estimate the prevalence and understand the spread of SARS-CoV-2 in Sweden, the Public Health Agency of Sweden, with support from the Swedish Armed Forces, conducted a series of point prevalence surveys between March and December 2020.
Methods: Sampling material and instructions on how to perform self-sampling of the upper respiratory tract were delivered to the homes of the participants. Samples were analysed by real-time PCR, and the participants completed questionnaires regarding symptoms.
A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April-May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 surveillance began in the WHO European Region on January 27, 2020, with the first European cases reported shortly after.
- By February 21, nine European countries had reported 47 cases, many linked to clusters in Germany and France, while others were infected in China.
- As of March 5, the total number of COVID-19 cases in the region surged to 4,250, highlighting the impact of delayed isolation efforts.
Objectives: The aim was to investigate risk factors for community-onset bloodstream infections with extended-spectrum β-lactamase-producing Enterobacteriaceae (EPE BSI).
Methods: It is mandatory to report EPE BSI to a national register at the Public Health Agency of Sweden. Using this register, we performed a population-based case-control study from 2007 to 2012 of 945 cases and 9390 controls.